THE Therapeutic Goods Administration (TGA) has accepted the recommendations of the Australian Influenza Vaccine Committee regarding the vaccines to be used in Australia.
This year there is a new A (H1N1)-like virus strain and a new A (H3N2)-like virus strain being used in the vaccines.
CLICK HERE for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Apr 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Apr 21
